Google invests millions in Mark Zuckerberg’s efforts to create a ‘virtual cell’

Google DeepMind, Meta, and the AI drug discovery startup Isomorphic Labs are jointly investing a substantial $300 million into Biohub, the nonprofit biomedical research organization established by Mark Zuckerberg and his wife, Priscilla Chan. This significant financial commitment, initially reported by Reuters, forms a crucial part of a larger $1.8 billion initiative. The overarching goal of this ambitious initiative is to construct advanced AI datasets. These datasets are envisioned to empower researchers, enabling them to "ask, predict, and answer biological questions digitally." Such capabilities are expected to revolutionize the discovery of novel methods for disease prevention and management, accelerating breakthroughs in medical science. Biohub, founded in 2016, has a core mission to combat diseases by pioneering the creation of a "virtual cell." This innovative virtual model will serve as a powerful tool for researchers, allowing them to conduct complex simulations and experiments in a digital environment, thereby gaining deeper insights into biological processes and disease mechanisms.